Guggenheim analyst Michael Schmidt initiates coverage on $SpringWorks Therapeutics (SWTX.US)$ with a buy rating, and sets the target price at $78.
According to TipRanks data, the analyst has a success rate of 49.4% and a total average return of 16.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $SpringWorks Therapeutics (SWTX.US)$'s main analysts recently are as follows:
Despite ongoing political and rate uncertainties which persistent as an overhang, the overall health of the Biopharma sector is seen as significantly better compared to its 2022 lows. For stocks under its review, preference continues toward those in late-stage clinical or early launch phases. However, Phase 1 clinical programs that present derisking data and impending catalysts are now viewed as key areas gaining investor interest.
The firm has slightly revised its Ogsiveo sales projections, now accounting for a reduced impact from ovarian granulosa cell tumor contribution and anticipating a slower sales increase in the EU by 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
